Created at Source Raw Value Validated value
June 25, 2024, noon usa

* age \<18 years * pregnancy (to be excluded using serum betahcg in women of childbearing age) * signs of infection, eczema or psoriasis at the application site * active malignancy * implanted cardiac pacemaker, deficrillator or other active implanted electrical devices * patient unable to consent * heart rate \<60/min * known vagal hypersensitivity * history of hemophilia

* age \<18 years * pregnancy (to be excluded using serum betahcg in women of childbearing age) * signs of infection, eczema or psoriasis at the application site * active malignancy * implanted cardiac pacemaker, deficrillator or other active implanted electrical devices * patient unable to consent * heart rate \<60/min * known vagal hypersensitivity * history of hemophilia

Sept. 29, 2021, 8:30 a.m. usa

- age <18 years - pregnancy (to be excluded using serum betahcg in women of childbearing age) - signs of infection, eczema or psoriasis at the application site - active malignancy - implanted cardiac pacemaker, deficrillator or other active implanted electrical devices - patient unable to consent - heart rate <60/min - known vagal hypersensitivity - history of hemophilia

- age <18 years - pregnancy (to be excluded using serum betahcg in women of childbearing age) - signs of infection, eczema or psoriasis at the application site - active malignancy - implanted cardiac pacemaker, deficrillator or other active implanted electrical devices - patient unable to consent - heart rate <60/min - known vagal hypersensitivity - history of hemophilia